1. Home
  2. QURE vs PEO Comparison

QURE vs PEO Comparison

Compare QURE & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • PEO
  • Stock Information
  • Founded
  • QURE 1998
  • PEO 1929
  • Country
  • QURE Netherlands
  • PEO United States
  • Employees
  • QURE N/A
  • PEO N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • PEO Finance/Investors Services
  • Sector
  • QURE Health Care
  • PEO Finance
  • Exchange
  • QURE Nasdaq
  • PEO Nasdaq
  • Market Cap
  • QURE 725.4M
  • PEO 596.4M
  • IPO Year
  • QURE 2007
  • PEO N/A
  • Fundamental
  • Price
  • QURE $17.27
  • PEO $20.74
  • Analyst Decision
  • QURE Strong Buy
  • PEO
  • Analyst Count
  • QURE 10
  • PEO 0
  • Target Price
  • QURE $37.20
  • PEO N/A
  • AVG Volume (30 Days)
  • QURE 1.4M
  • PEO 35.4K
  • Earning Date
  • QURE 07-31-2025
  • PEO 01-01-0001
  • Dividend Yield
  • QURE N/A
  • PEO 5.93%
  • EPS Growth
  • QURE N/A
  • PEO N/A
  • EPS
  • QURE N/A
  • PEO N/A
  • Revenue
  • QURE $20,201,000.00
  • PEO N/A
  • Revenue This Year
  • QURE $27.16
  • PEO N/A
  • Revenue Next Year
  • QURE $248.21
  • PEO N/A
  • P/E Ratio
  • QURE N/A
  • PEO N/A
  • Revenue Growth
  • QURE 6.30
  • PEO N/A
  • 52 Week Low
  • QURE $3.73
  • PEO $19.22
  • 52 Week High
  • QURE $19.18
  • PEO $23.80
  • Technical
  • Relative Strength Index (RSI)
  • QURE 67.53
  • PEO 57.08
  • Support Level
  • QURE $14.75
  • PEO $20.22
  • Resistance Level
  • QURE $15.50
  • PEO $20.69
  • Average True Range (ATR)
  • QURE 1.07
  • PEO 0.36
  • MACD
  • QURE 0.16
  • PEO 0.06
  • Stochastic Oscillator
  • QURE 93.40
  • PEO 92.16

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About PEO Adams Natural Resources Fund Inc.

Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.

Share on Social Networks: